2m 2m 2m 2m 2m 2m 2m
NURIX THERAPEUTC-RG (NRIX)
NASDAQ
$18.63-$0.02 (-0.13%)
Price as of Jun 23, 2026 4:37 PM EDT- $1.9BMarket Cap
- 55.68%1-Year Change
- BiotechnologyIndustry
NURIX THERAPEUTC-RG (NRIX)
$18.63-$0.02 (-0.13%)
NRIX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $18.65 | ||
Change | +$1.10 (+6.27%) | ||
Open | $17.83 | ||
High | $18.85 | ||
Low | $17.83 | ||
Previous Close | $17.55 | ||
Volume | 2,214,256 | ||
30-Day Average Volume | 3,238,246 | ||
1-Week Change | 9.45% | ||
1-Month Change | 6.57% | ||
1-Year Change | 55.68% | ||
3-Year Change | 83.02% | ||
5-Year Change | -35.38% | ||
Fundamentals | |||
Shares Outstanding | 103.4M | ||
Total Assets | $636.1M | ||
Market Cap | $1.9B | ||
Enterprise Value | $1.9B | ||
Period: QTR TTM FY | |||
Revenue | $6.3M | ||
Net Income | -$87.2M | ||
Free Cash Flow | -$73.0M | ||
EBIT | -$87.2M | ||
EBITDA | -$85.0M | ||
Net Working Capital | $462.2M | ||
EPS | -$0.79 | ||
Enterprise Value/EBITDA | -22 | ||
Enterprise Value/Revenue | 297 | ||
P/B | 4 | ||
P/E | -24 | ||
PEG | -6 | ||
Price/Free Cash Flow | -26 | ||
Price/Operating Cash Flow | -27 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue